Chief Operating Officer
Mr. Lee leads the Eyegenix™ division in the development of an artificial cornea for the treatment of corneal blindness. Mr. Lee comes to SKAI Ventures with 13 years of medical device experience. Previously, Mr. Lee led the research and development team at Coalescent Surgical, Inc., a venture funded medical device startup focused on minimally invasive cardiovascular bypass and valve fixation, acquired by Medtronic Inc in 2004.
Prior to his work at Coalescent, Mr. Lee led R&D efforts at two venture financed companies: Vivant Medical which was acquired by Valley Lab/Tyco, and AneuRx, which was acquired by Medtronic Inc. Mr. Lee received his MS from the Georgia Institute of Technology and is a registered Professional Engineer in the state of CA.